Alkhalil, E. et al. 2025. BioNTech/Pfizer (BNT162b2) COVID-19 mRNA vaccine: manufacturing, immunogenicity, efficacy and safety. Prospects in Pharmaceutical Sciences. 23, 1 (Feb. 2025), 31–46. DOI:https://doi.org/10.56782/pps.292.